Top Markets
#1 DogBull DogBull +73.84%
#2 Siren Siren +32.04%
#3 OriginTrail OriginTrail +13.43%
#4 龙虾 (Lobster) 龙虾 (Lobster) +10.56%
#5 Verus Coin Verus Coin +10.55%
#6 COTI COTI +9.14%
#7 Falcon Finance Falcon Finance +8.82%
#8 PulseChain PulseChain +6.82%
#9 Tutorial Tutorial +6.18%
#10 DODO DODO +5.82%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Lansen Pharmaceutical Holdings Limited Lansen Pharmaceutical Holdings Limited

Lansen Pharmaceutical Holdings Limited

0503
Rank in Stocks #22050
Lansen Pharmaceutical Holdings Limited, an investment holding company,... Lansen Pharmaceutical Holdings Limited, an investment holding company, concentrates on the research, manufacturing, and global distribution of niche pharmaceutical drugs. These specialized medicines primarily address conditions in rheumatology and dermatology, serving both the People's Republic of China and international markets. The company's business operations are organized into three distinct divisions: Pharmaceuticals, Cosmetic Products, and Healthcare Products. Its product range includes generic traditional Chinese medicines, various cosmetic goods, and health-related items. Established in 2001, its main offices are situated in Ningbo, China. Lansen Pharmaceutical Holdings Limited operates as a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
Share Price
$0.22961818
Last synced: 2023-12-18
Market Cap
$95.29M
Change (1 day)
0.16%
Change (1 year)
0.00%
Country
CN
Trade Lansen Pharmaceutical Holdings Limited (0503)

Category

Healthcare
P/E ratio for Lansen Pharmaceutical Holdings Limited (0503)
P/E ratio as of 2026 TTM: 0
According to Lansen Pharmaceutical Holdings Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Lansen Pharmaceutical Holdings Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.